US Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
US Financial Advisors's XBI Position: Q2 2021 in Review
US Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 1,636 shares — an estimated $222K sold.
US Financial Advisors first reported a position in XBI in Q4 2020 and held it in 2 quarters. The position peaked at $222K in Q1 2021. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.
- US Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
- US Financial Advisors sold 1,636 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $222K.
- US Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 2 quarters.
- US Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $222K in Q1 2021.
- 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.
Based on US Financial Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.